MVP vs RHT

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

RHT

RESONANCE FPO [RHT]

60MEDIUM-HIGH

Score Breakdown

MVP RHT
Technical
68
52
Catalyst
50
52
Sentiment
50
50
Fundamental
95
91
Momentum
51
76
Risk Gate
50
50

Key Metrics

MVP Metric RHT
$52.9MMarket Cap$28.6M
214KAvg Volume (20d)388K
N/AShort InterestN/A
$0.76552-Week High$0.068
$0.36552-Week Low$0.033
+2.2%Daily Change-3.3%
$0.460Reference Price$0.058
+1.1%ROE+14.8%
+1.5%Profit Margin+9.6%

Active Signals

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

RHT Signals

●MACD momentum is losing steam
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.8x)
●Strong revenue growth (+31%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●Small-cap ($20-100M)

Ask Scout AI to compare MVP and RHT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs IMM →IMM vs RHT →AHC vs RHT →ATH vs MVP →CUV vs EYE →
MVP Full Analysis → RHT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).